| scholarly article | Q13442814 |
| P50 | author | Richard S. Legro | Q40316671 |
| Andrea D Coviello | Q47502307 | ||
| P2093 | author name string | Andrea Dunaif | |
| Susan Sam | |||
| P2860 | cites work | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 |
| Metabolic phenotype in the brothers of women with polycystic ovary syndrome | Q33962557 | ||
| Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels | Q34227587 | ||
| Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome | Q34598493 | ||
| The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. | Q35135723 | ||
| Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. | Q35597056 | ||
| Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome | Q35597070 | ||
| Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome | Q35995837 | ||
| Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. | Q36758555 | ||
| The link between abdominal obesity and the metabolic syndrome | Q37161474 | ||
| Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome | Q37262330 | ||
| Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects | Q37355732 | ||
| Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study | Q40760488 | ||
| Metabolic profile in sons of women with polycystic ovary syndrome | Q42524146 | ||
| Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study | Q43843236 | ||
| Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome. | Q44075861 | ||
| A comparison of the prevalence of the metabolic syndrome using two proposed definitions | Q44333376 | ||
| Glucose Intolerance, Insulin Resistance, and Hyperandrogenemia in First Degree Relatives of Women with Polycystic Ovary Syndrome | Q44427438 | ||
| The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study | Q44473188 | ||
| Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. | Q44685104 | ||
| Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. | Q44757133 | ||
| Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. | Q44865591 | ||
| Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis | Q45004056 | ||
| Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study | Q45048805 | ||
| The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study | Q45145832 | ||
| Relative risks of the metabolic syndrome according to the degree of insulin resistance in apparently healthy Korean adults | Q45237797 | ||
| Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance | Q46774556 | ||
| Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome | Q46921371 | ||
| Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. | Q51035704 | ||
| Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. | Q51464160 | ||
| Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. | Q51494027 | ||
| Testosterone concentrations in women and men with NIDDM. | Q51595541 | ||
| Polycystic Ovary Syndrome | Q56092373 | ||
| Lower endogenous androgens predict central adiposity in men | Q67875625 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| polycystic ovary syndrome | Q500816 | ||
| metabolic syndrome | Q657193 | ||
| polycystic ovary | Q5547896 | ||
| P304 | page(s) | 4361-4366 | |
| P577 | publication date | 2009-10-16 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity | |
| P478 | volume | 94 |
| Q48138914 | A Single Bout of Electroacupuncture Remodels Epigenetic and Transcriptional Changes in Adipose Tissue in Polycystic Ovary Syndrome. |
| Q41108966 | Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys |
| Q36334951 | Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome |
| Q34878055 | Assessing and treating insulin resistance in women with polycystic ovarian syndrome |
| Q85029538 | Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro |
| Q50056959 | Cardiometabolic Risk in PCOS: More than a Reproductive Disorder |
| Q89802309 | Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life? |
| Q35906974 | Defining the role of bariatric surgery in polycystic ovarian syndrome patients |
| Q36360786 | Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. |
| Q39502485 | Establishment of polycystic ovary syndrome-derived human embryonic stem cell lines |
| Q30303066 | Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome |
| Q35108260 | Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome |
| Q36607455 | Familial aggregation of circulating C-reactive protein in polycystic ovary syndrome |
| Q37060258 | Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome |
| Q36429617 | Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction |
| Q36306120 | Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring |
| Q40946230 | Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS) |
| Q50056205 | Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis |
| Q30371644 | Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome. |
| Q36716040 | Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity |
| Q88098767 | Polycystic ovary syndrome |
| Q37832125 | Polycystic ovary syndrome: etiology, pathogenesis and diagnosis |
| Q33750469 | Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India |
| Q28390200 | Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome |
| Q28395801 | Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus |
| Q35233754 | State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS). |
| Q92059141 | Synergistic Effects of Hyperandrogenemia and Obesogenic Western-style Diet on Transcription and DNA Methylation in Visceral Adipose Tissue of Nonhuman Primates |
| Q41640666 | The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited |
| Q91636068 | Transgenerational Inheritance of Reproductive and Metabolic Phenotypes in PCOS Rats |
Search more.